Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

NCT05682131 is registered in ClinicalTrials.gov with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor.

NCT NCT05682131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05682131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase
Phase 4
Overall status
Recruiting
Start date
September 27, 2022
Completion date
September 27, 2030
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arsenic trioxide, childhood all